[SGMO] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
24-Feb-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -2,519.61%
YoY- -991.42%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 28,563 27,872 26,280 25,800 57,763 21,553 13,076 68.27%
PBT -47,602 -47,150 -45,677 -40,567 -1,271 -35,965 -42,974 7.04%
Tax 86 24 262 108 237 -36 -61 -
NP -47,688 -47,169 -45,933 -40,604 -1,550 -35,929 -42,913 7.28%
Tax Rate - - - - - - - -
Total Cost 76,251 75,041 72,213 66,404 59,313 57,482 55,989 22.84%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -166.96 -169.23 -174.78 -157.38 -2.68 -166.70 -328.18 -36.24%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.33 -0.33 -0.32 -0.29 -0.01 -0.26 -0.37 -7.33%
EPS Diluted -0.33 -0.33 -0.32 -0.29 -0.01 -0.26 -0.37 -7.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.